NCT00537979View on ClinicalTrials.gov

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

PHASE4CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Secondary HyperparathyroidismDialysis
Interventions
DRUG

Paricalcitol injection

Most recent iPTH level in pg/mL divided by 100 = dose in mcg; dose is rounded down to nearest mcg and administered 3x weekly

DRUG

Paricalcitol capsules

Most recent iPTH level in pg/mL divided by 80 = dose in mcg; dose is rounded down to nearest mcg and administered 3x weekly

Trial Locations (12)

CP 62900

Site Ref # / Investigator 19391, Jojutla Morelos

CP 01030

Site Ref # / Investigator 19392, Mexico City

CP 02080

Site Ref # / Investigator 19397, Mexico City

CP 03650

Site Ref # / Investigator 19396, Mexico City

CP 03900

Site Ref # / Investigator 19389, Mexico City

CP 14000

Site Ref # / Investigator 19390, Mexico City

CP 14080

Site Ref # / Investigator 19393, Mexico City

CP 14140

Site Ref # / Investigator 19394, Mexico City

CP 16070

Site Ref # / Investigator 19395, Mexico City

CP 72400

Site Ref # / Investigator 19399, Puebla City

CP 45116

Site Ref # / Investigator 19398, Zapopan

CP 45150

Site Ref # / Investigator 19388, Zapopan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY